SCHEMBL2807358

SCHEMBL2807358

CC/C(=C\Oc1ccc(OC)cc1)C(=O)Nc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.54
ALDH1A1 P00352 5/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
GAA P10253 2/20 0.51
HTT P42858 1/20 0.51
RAB9A P51151 6/20 0.49
NPC1 O15118 5/20 0.49
HDAC3 O15379 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
LMNA P02545 1/20 0.48
TP53 P04637 1/20 0.48
MAPT P10636 5/20 0.48
HIF1A Q16665 1/20 0.47
FPR2 P25090 1/20 0.47
CYP1A2 P05177 3/20 0.47
CYP2C19 P33261 3/20 0.47
EGFR P00533 1/20 0.46
MMP1 P03956 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2807360 1.00 KMT2A (0.54) KMT2AALDH1A1SMN1; SMN2GAAHTT
SCHEMBL2813927 0.92 ALDH1A1 (0.46) KMT2AALDH1A1SMN1; SMN2GAARAB9A
SCHEMBL2813929 0.92 ALDH1A1 (0.46) KMT2AALDH1A1SMN1; SMN2GAARAB9A
SCHEMBL2808857 0.89 ALDH1A1 (0.44) KMT2AALDH1A1SMN1; SMN2GAARAB9A
SCHEMBL2808854 0.89 ALDH1A1 (0.44) KMT2AALDH1A1SMN1; SMN2GAARAB9A
SCHEMBL3985979 0.88 CYP19A1 (0.43) KMT2AALDH1A1GAARAB9ALMNA
SCHEMBL2811864 0.88 NPC1 (0.52) KMT2AALDH1A1SMN1; SMN2GAARAB9A
SCHEMBL2811866 0.88 NPC1 (0.52) KMT2AALDH1A1SMN1; SMN2GAARAB9A
SCHEMBL2811039 0.84 NPSR1 (0.48) KMT2AALDH1A1SMN1; SMN2GAARAB9A
SCHEMBL2811036 0.84 NPSR1 (0.48) KMT2AALDH1A1SMN1; SMN2GAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 KMT2A 3324/4885ALDH1A1 405/4885SMN1; SMN2 1135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.